Evaluation of Oncoxin-Viusid® in Head and Neck Cancer

NCT03541772 PHASE2 COMPLETED

Nutritional supplements containing antioxidants seem to decrease toxicity associated with Radiotherapy (RT) and Chemotherapy (CT) in patients with malignant head and neck tumors. Oncoxin-Viusid® (OV) is a nutritional supplement with antioxidant, immunomodulator and antitumor effects.

Details

Lead sponsor	Catalysis SL
Phase	PHASE2
Status	COMPLETED
Enrolment	60
Start date	Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Oct 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Head Cancer Neck

Interventions

• Oncoxin-Viusid®
• Placebo

Countries

Cuba